Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haogao Gu

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Nature Communications|May 26, 2022
SARS-CoV-2 accessory proteins reveal distinct serological signatures in childrenAsmaa Hachim, Haogao Gu, Otared Kavian, et al.
Virology Journal|March 22, 2024
Cross-neutralizing antibody against emerging Omicron subvariants of SARS-CoV-2 in infection-naïve individuals with homologous BNT162b2 or BNT162b2(WT + BA.4/5) bivalent booster vaccinationSamuel M S Cheng, Chris K P Mok, John K C Li, et al.
Emerging Infectious Diseases|June 27, 2018
Circulation of Influenza A(H5N8) Virus, Saudi ArabiaHussain Al-Ghadeer, Daniel K W Chu, Ehab M A Rihan, et al.
Medrxiv : the Preprint Server for Health Sciences|June 30, 2021
SARS-CoV-2 under an elimination strategy in Hong KongHaogao Gu, Ruopeng Xie, Dillon C Adam, et al.
Nature Communications|February 9, 2022
Genomic epidemiology of SARS-CoV-2 under an elimination strategy in Hong KongHaogao Gu, Ruopeng Xie, Dillon C Adam, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Nature Communications|May 26, 2022
SARS-CoV-2 accessory proteins reveal distinct serological signatures in childrenAsmaa Hachim, Haogao Gu, Otared Kavian, et al.
Virology Journal|March 22, 2024
Cross-neutralizing antibody against emerging Omicron subvariants of SARS-CoV-2 in infection-naïve individuals with homologous BNT162b2 or BNT162b2(WT + BA.4/5) bivalent booster vaccinationSamuel M S Cheng, Chris K P Mok, John K C Li, et al.
Emerging Infectious Diseases|June 27, 2018
Circulation of Influenza A(H5N8) Virus, Saudi ArabiaHussain Al-Ghadeer, Daniel K W Chu, Ehab M A Rihan, et al.
Medrxiv : the Preprint Server for Health Sciences|June 30, 2021
SARS-CoV-2 under an elimination strategy in Hong KongHaogao Gu, Ruopeng Xie, Dillon C Adam, et al.
Nature Communications|February 9, 2022
Genomic epidemiology of SARS-CoV-2 under an elimination strategy in Hong KongHaogao Gu, Ruopeng Xie, Dillon C Adam, et al.
Pageof 5